Elsevier recently announced the launch of Entellect, a new cloud-based data platform designed to help life sciences companies overcome the challenges of modern research and development by enriching external data and delivering it in an environment friendly with artificial intelligence (AI). PR Newswire brought this interesting information to our attention in their article, “Elsevier Launches Entellect™ Platform, Unlocking Value by Creating AI-ready Life Sciences Data.”
The cost of bringing a new drug to market continues to rise. Because of this life sciences companies are looking for more efficient ways to analyze data. The new platform can save time and costs by breaking down the silos that prevent information sharing and collaboration, thereby connecting drug, target, and disease data to deliver discoverable and model-ready information.
Access to data is key in this data driven world. All decisions and processes are dictated by the data. This is most evident in the field of big data, where data and information are the basis of all actions – gathering and analyzing of data is the core motivator.
Melody K. Smith
Sponsored by Data Harmony, a unit of Access Innovations, the world leader in indexing and making content findable.
